Lodestone Biomedical Inc.
CAGE Code: 79C36
NCAGE Code: 79C36
Status: Active
Type: Commercial Supplier
Summary
Lodestone Biomedical Inc. is an Active Commercial Supplier with the Cage Code 79C36.
Address
10 Water St Ste 265
Lebanon NH 03766-1631
United States
Points of Contact
No Points of Contact...
Related Information
No Related Information...
People who viewed this 'CAGE Code' also viewed...
Trivisions Inc Wrinkle Inc Quality Inn Lebanon, Pa Hetrick Computer Systems Inc. Kg Projections, Inc. The Barbour Company Pipeline Transport Llc Groundspeed Llc Detroit Tool And Engineering Co Detroit Tool Metal Products Co. Emergency Management Resources P O Boone County Mentoring Partnership, Lebanon County Regional Police Solstad Erling L Contractor Omc Aluminum Boat Group I V C Sensors Inc Training Technologies Inc Pennsylvania Counceling Services Rpmi Material Handling Inc Infotech Computer Systems
Frequently Asked Questions (FAQ) for CAGE 79C36
- What is CAGE Code 79C36?
- 79C36 is the unique identifier used by NATO Organizations to reference the physical entity known as Lodestone Biomedical Inc. located at 10 Water St Ste 265, Lebanon NH 03766-1631, United States.
- Who is CAGE Code 79C36?
- 79C36 refers to Lodestone Biomedical Inc. located at 10 Water St Ste 265, Lebanon NH 03766-1631, United States.
- Where is CAGE Code 79C36 Located?
- CAGE Code 79C36 is located in Lebanon, NH, USA.
Contracting History for CAGE 79C36 Most Recent 25 Records
- 75N91022C00043
- Topic 405: Intratumoral Biosensing For In Vivo Pharmacotyping
- 10 Mar 2023
- Topic 405: Intratumoral Biosensing For In Vivo Pharmacotyping
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $2,050,000.00
- Department Of Health And Human Services (Hhs)
- 75N91022C00043
- Topic 405: Intratumoral Biosensing For In Vivo Pharmacotyping
- 15 Sep 2022
- Topic 405: Intratumoral Biosensing For In Vivo Pharmacotyping
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $2,050,000.00
- Department Of Health And Human Services (Hhs)
- 75N91020C00021
- Topic #405 Sbir Phase I - In Vivo Pharmacotyping Of Combination Therapy In Primary Brain Tumors
- 11 Jun 2021
- Topic #405 Sbir Phase I - In Vivo Pharmacotyping Of Combination Therapy In Primary Brain Tumors
- Nih Nci
- Department Of Health And Human Services (Hhs)
- $455,000.00
- Department Of Health And Human Services (Hhs)